The Pharmaceutical Journal

The Pharmaceutical Journal is a specialized magazine that focuses on different areas of pharmacy, such as pharmacology and pharmaceutics. It is published by the Royal Pharmaceutical Society, which is the official organization for pharmacists in the UK, previously known as the Royal Pharmaceutical Society of Great Britain.

National, Trade/B2B

English

Journal

Outlet metrics

Domain Authority

Ranking

Global

#196633

United Kingdom

#29332

Health/Pharmacy

#29

Traffic sources

Monthly visitors

Articles

Pharmacy First uptake ‘not what we would like it to be’, says minister

1 week ago | pharmaceutical-journal.com | Sophie Willis

The take-up of Pharmacy First is “not what we would like it to be”, pharmacy minister Stephen Kinnock has said. Speaking at a on 17 June 2025, Kinnock said that in response to low usage of Pharmacy First, the government is “looking at options” to boost awareness of the service and reduce pressure on pharmacists by enabling them “to operate at the top of their licence”. These options include streamlining dispensing, with forthcoming hub-and-spoke legislation playing a key role, he added.
GPhC highlights need to improve performance in five-year strategy

1 week ago | pharmaceutical-journal.com | Sophie Willis

The General Pharmaceutical Council (GPhC) has launched its strategic plan for 2025–2030, outlining priorities to strengthen public trust, regulatory performance and support for the pharmacy profession.
How we reduced polypharmacy by 1.6 medicines per patient in a care home

1 week ago | pharmaceutical-journal.com | David Jones

A structured medication review (SMR) is an evidence-based, comprehensive and holistic evaluation of patients’ medications, where the clinician and patient work together as equals in a shared-decision making conversation to understand the risks and benefits of the medicines, taking into account the patients’ ideas, concerns and expectations.
Amandeep Doll appointed as RPS director for England

1 week ago | pharmaceutical-journal.com | Corrinne Burns

Amandeep Doll has been appointed as the director for England at the Royal Pharmaceutical Society (RPS). Doll has worked at the RPS for eight years and currently holds the position of head of engagement and professional belonging, leading on the implementation of the Society’s Inclusion and Diversity (I&D) strategy, which launched in 2020. She is also a specialist medical pharmacist at Nottingham University Hospitals NHS Trust.
NHS App to be used to recruit patients for clinical trials

1 week ago | pharmaceutical-journal.com | Joanna Robertson

Millions of patients can now sign up to take part in clinical trials via the NHS App, the government has said.
NICE recommends 'breakthrough' therapy for blood cancer

2 weeks ago | pharmaceutical-journal.com | Corrinne Burns

The National Institute for Health and Care Excellence (NICE) has recommended a targeted therapy for blood cancer that offers “significant survival benefits” for some patients on the NHS in England. In draft guidance, published on 13 June 2025, NICE approved belantamab mafodotin (Blenrep; GSK), in combination with bortezomib (Velcade; Janssen-Cilag) and dexamethasone, as a second-line treatment for patients with multiple myeloma.
Integrated digital patient care records to be created following law change

2 weeks ago | pharmaceutical-journal.com | Joanna Robertson

Integrated digital patient care records will be created in Scotland after MSPs approved legislative amendments in the Scottish Parliament.
UK government says it does not support safe drug consumption rooms

2 weeks ago | pharmaceutical-journal.com | Sophie Willis

Speaking at the House of Commons Scottish Affairs Committee’s inquiry into the Glasgow safe drug consumption facility (SDCF), the UK government has confirmed that it does not support safe drug consumption rooms. Minister for policing and crime prevention, Dame Diana Johnson, told the inquiry, on 4 June 2025: “I really want to be clear with you: we do not support drug consumption facilities.
Chronic heart failure deaths could fall by 3,000 per year following updated guidance, says NICE

2 weeks ago | pharmaceutical-journal.com | Corrinne Burns

Chronic heart failure deaths in England could be cut by around 3,000 per year following the introduction of updated guidance on treatment for the condition, the National Institute for Health and Care Excellence (NICE) has said. In a statement published on 10 June 2025 alongside draft updated guidance, NICE also said that the recommendations in ‘Chronic heart failure in adults: diagnosis and management‘ could prevent around 5,000 hospital admissions annually.
MHRA publishes ‘world first’ decentralised manufacturing guidance

2 weeks ago | pharmaceutical-journal.com | Corrinne Burns

Guidance on decentralised, or point-of care (POC), medicines manufacture has been published by the Medicines and Healthcare Regulatory Agency (MHRA), in what the body said is a world first.